Salimi, Azam
Schroeder, Kema Marlen
Schemionek-Reinders, Mirle
Vieri, Margherita
Maletzke, Saskia
Gezer, Deniz
Masouleh, Behzad Kharabi
Appelmann, Iris
Funding for this research was provided by:
RWTH Aachen University
Article History
Received: 20 June 2021
Accepted: 6 June 2022
First Online: 6 July 2022
Declarations
:
: Primary bone marrow cells from patients with multiple myeloma were kindly provided by RWTH Biobank, RWTH Aachen University Hospital, Germany, in accordance with the Ethics committee of Faculty Medicine RWTH Aachen after written informed consent. All methods were performed in accordance with the relevant guidelines and regulations.
: IA and BKM received funding from Takeda Pharmaceutical®. Other authors have no competing interest.